These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 28296761
1. Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic review and meta-analysis. Qiu Q, Huang J, Lin Y, Shu X, Fan H, Tu Z, Zhou Y, Xiao C. Medicine (Baltimore); 2017 Mar; 96(11):e6337. PubMed ID: 28296761 [Abstract] [Full Text] [Related]
3. Methotrexate pharmacogenetics in rheumatoid arthritis: a status report. Malik F, Ranganathan P. Pharmacogenomics; 2013 Feb; 14(3):305-14. PubMed ID: 23394392 [Abstract] [Full Text] [Related]
4. Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis. Qiu Q, Huang J, Shu X, Fan H, Zhou Y, Xiao C. Sci Rep; 2017 Mar 07; 7():44015. PubMed ID: 28266606 [Abstract] [Full Text] [Related]
5. Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis. Milic V, Jekic B, Lukovic L, Bunjevacki V, Milasin J, Novakovic I, Damnjanovic T, Popovic B, Maksimovic N, Damjanov N, Radunovic G, Pejnovic N, Krajinovic M. Clin Exp Rheumatol; 2012 Mar 07; 30(2):178-83. PubMed ID: 22324981 [Abstract] [Full Text] [Related]
7. Polymorphism of genes involved in methotrexate pathway: Predictors of response to methotrexate therapy in Indian rheumatoid arthritis patients. Singh A, Gangadharan H, Gupta V, Patro PS, Misra R, Aggarwal A. Int J Rheum Dis; 2021 May 07; 24(5):654-662. PubMed ID: 33780152 [Abstract] [Full Text] [Related]
8. Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. Ranganathan P, Culverhouse R, Marsh S, Mody A, Scott-Horton TJ, Brasington R, Joseph A, Reddy V, Eisen S, McLeod HL. J Rheumatol; 2008 Apr 07; 35(4):572-9. PubMed ID: 18381794 [Abstract] [Full Text] [Related]
9. Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity. Sala-Icardo L, Lamana A, Ortiz AM, García Lorenzo E, Moreno Fresneda P, García-Vicuña R, González-Álvaro I. Reumatol Clin; 2017 Apr 07; 13(6):318-325. PubMed ID: 27751863 [Abstract] [Full Text] [Related]
10. Polymorphisms in genes involved in the mechanism of action of methotrexate: are they associated with outcome in rheumatoid arthritis patients? Salazar J, Moya P, Altés A, Díaz-Torné C, Casademont J, Cerdà-Gabaroi D, Corominas H, Baiget M. Pharmacogenomics; 2014 Jun 07; 15(8):1079-90. PubMed ID: 25084201 [Abstract] [Full Text] [Related]
11. Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism. Bohanec Grabar P, Logar D, Lestan B, Dolzan V. Eur J Clin Pharmacol; 2008 Nov 07; 64(11):1057-68. PubMed ID: 18607581 [Abstract] [Full Text] [Related]
12. ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients. Takatori R, Takahashi KA, Tokunaga D, Hojo T, Fujioka M, Asano T, Hirata T, Kawahito Y, Satomi Y, Nishino H, Tanaka T, Hirota Y, Kubo T. Clin Exp Rheumatol; 2006 Nov 07; 24(5):546-54. PubMed ID: 17181924 [Abstract] [Full Text] [Related]
13. Reduced folate carrier-1 80G > A gene polymorphism is not associated with methotrexate treatment response in South Indian Tamils with rheumatoid arthritis. Muralidharan N, Mariaselvam CM, Mithun CB, Negi VS. Clin Rheumatol; 2016 Apr 07; 35(4):879-85. PubMed ID: 25771854 [Abstract] [Full Text] [Related]
15. Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis. Weisman MH, Furst DE, Park GS, Kremer JM, Smith KM, Wallace DJ, Caldwell JR, Dervieux T. Arthritis Rheum; 2006 Feb 07; 54(2):607-12. PubMed ID: 16447238 [Abstract] [Full Text] [Related]
17. A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis. Wessels JA, van der Kooij SM, le Cessie S, Kievit W, Barerra P, Allaart CF, Huizinga TW, Guchelaar HJ, Pharmacogenetics Collaborative Research Group. Arthritis Rheum; 2007 Jun 07; 56(6):1765-75. PubMed ID: 17530705 [Abstract] [Full Text] [Related]
18. Association of hyperhomocysteinemia with genetic variants in key enzymes of homocysteine metabolism and methotrexate toxicity in rheumatoid arthritis patients. Chaabane S, Messedi M, Akrout R, Ben Hamad M, Turki M, Marzouk S, Keskes L, Bahloul Z, Rebai A, Ayedi F, Maalej A. Inflamm Res; 2018 Aug 07; 67(8):703-710. PubMed ID: 29796841 [Abstract] [Full Text] [Related]
19. Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms. Lima A, Monteiro J, Bernardes M, Sousa H, Azevedo R, Seabra V, Medeiros R. Biomed Res Int; 2014 Aug 07; 2014():368681. PubMed ID: 24967362 [Abstract] [Full Text] [Related]
20. Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis. Plaza-Plaza JC, Aguilera M, Cañadas-Garre M, Chemello C, González-Utrilla A, Faus Dader MJ, Calleja MA. OMICS; 2012 Nov 07; 16(11):589-95. PubMed ID: 23095111 [Abstract] [Full Text] [Related] Page: [Next] [New Search]